Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

IF 5.1 2区 医学 Q1 ONCOLOGY
Silvia Secco, Alberto Olivero, Mattia Longoni, Paolo Dell’Oglio, Stefano Tappero, Edoardo Dibilio, Tommaso Saccucci, Giampaolo Siena, Aldo Massimo Bocciardi, Antonio Galfano, Luca Cindolo
{"title":"Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure","authors":"Silvia Secco, Alberto Olivero, Mattia Longoni, Paolo Dell’Oglio, Stefano Tappero, Edoardo Dibilio, Tommaso Saccucci, Giampaolo Siena, Aldo Massimo Bocciardi, Antonio Galfano, Luca Cindolo","doi":"10.1038/s41391-024-00892-2","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background/Objectives</h3><p>Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning.</p><h3 data-test=\"abstract-sub-heading\">Subjects/Methods</h3><p>Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.</p>","PeriodicalId":20727,"journal":{"name":"Prostate Cancer and Prostatic Diseases","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate Cancer and Prostatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41391-024-00892-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives

Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning.

Subjects/Methods

Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS).

Results

No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA.

Conclusions

SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.

Abstract Image

在 iTIND 手术前使用 Schelin 导管进行经尿道前列腺内麻醉 (TUIA)
背景/目的为了支持良性前列腺增生症(BPH)手术的微创原则,我们首次评估了在 iTIND 定位前使用 Schelin 导管® (SC) 进行经尿道前列腺内麻醉(TUIA)的情况。在 23 例入组患者中,11 例(48%)通过 SC 接受了 TUIA,其余患者则接受了标准麻醉方案。采用视觉模拟量表(VAS)对疼痛进行评估。结果 在设备植入和移除过程中,未观察到不同组别之间的疼痛差异。相反,在 24 小时(1.0 对 3.0)和 48 小时(1.0 对 2.5)的随访中,VAS 评分中位数明显低于 TUIA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases 医学-泌尿学与肾脏学
CiteScore
10.00
自引率
6.20%
发文量
142
审稿时长
6-12 weeks
期刊介绍: Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信